| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.043 | 0.4 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | 0.05 | 0.4 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.4 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |